Table 9.
Effects of naringenin: Human studies.
| Naringenin Concentration | Blood Measures | Other Measures | Reference |
|---|---|---|---|
| 3.7–5.0 mg/kg/day | ↓ Cholesterol levels | ↓ T2DM risk ↓ Asthma ↓ Ischemic heart disease ↓ Mortality |
[96] |
| 273.08 mg/mL | ↓ Triglyceride levels ↑ HDL levels |
↓ Obesity ↓ Systolic and diastolic blood pressure |
[97] |
| 400 mg/capsule/day | ↓ Cholesterol levels ↓ LDL levels ↓ ApoB levels ↓ TBARS levels |
↑ SOD activity ↑ CAT activity ↓ GSH-Px activity |
[98] |
| 900 mg/kg | ↓ Glucose levels | ↓ Body weight | [99] |
Type 2 diabetic mellitus (T2DM); Glutathione peroxidase (GSH-Px).